Skip to main content
NIH funding notice RFA-RM-17-015

Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)

Closed on November 2, 2017.

Posted
August 15, 2017
Close date
November 2, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $781,647 in first-year total cost, median $781,647.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BCMB-P (50)]1

Most frequent institutions

  1. MAYO CLINIC ROCHESTER1
Competing awards under RFA-RM-17-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Mayo Clinic Undiagnosed Disease Network Metabolomics Core1U01TR002471-01LANZA, IAN ROGLESBEE, DEVINMAYO CLINIC ROCHESTER, MN$781,647ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.